Treatment outcomes in oligometastatic non-small-cell lung cancer: A single-centre experience.
Pınar Akın KabalakDerya KızılgözÜlkü YılmazTuba İnal CengizEvrim TunçŞebnem YamanSelim Şakir Erkmen GülhanPublished in: The clinical respiratory journal (2020)
In well-selected NSCLC patients with limited metastasis, survival rates can reach up to 3 years, even in a geriatric population. Clinical N staging and co-morbidity are important prognostic factors.